Research and industry brief on academic findings and a biotech peptide program offering fresh insights into treating chronic neuropathic pain.
Key Takeaways
- As a novel therapeutic target for neuropathic pain and reports that LAT8881
- Titled Lanthionine synthetase C-like protein 1 (LanCL1)
- Latest longevity science, investment, innovation and insight, delivered every morning